Costco Wholesale Corp /New
—- Market cap
- —
- Debt
- —
- Cash
- −$14.16B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: COST stock price vs CI: inconclusive — current versus $228.38 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CI's multiple
Implied fair value · at COST's multiple
Needs COST P/E.
Snapshot Sep 9, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
COSTCO WHOLESALE CORP /NEW · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
The Cigna Group · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Walmart Inc.
COST vs WMT
TARGET CORP
COST vs TGT
KROGER CO
COST vs KR
DOLLAR GENERAL CORP
COST vs DG
AMAZON COM INC
COST vs AMZN
HOME DEPOT, INC.
COST vs HD
UNITEDHEALTH GROUP INC
COST vs UNH
CVS HEALTH Corp
COST vs CVS
HUMANA INC
COST vs HUM
CENTENE CORP
COST vs CNC
WEST PHARMACEUTICAL SERVICES INC
COST vs WST
BAXTER INTERNATIONAL INC
COST vs BAX
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe COST’s premium ROIC, stronger balance sheet, and historical range justify a valuation above CI’s multiples, then hold or selectively accumulate only on pullbacks because the current P/E-based model still implies substantial downside relative to CI.
On a P/E basis, COST at 52.0x trades far above CI at 12.7x, which mechanically drives the model’s implied downside of -75.5% to $231.93. However, COST also carries much stronger quality and balance-sheet characteristics, so the headline valuation gap overstates the comparability risk.
Supporting Metrics